探讨同型半胱氨酸联合超敏C-反应蛋白和血脂类项目检测在冠心病中的临床价值  

Investigation of clinical value of homocysteine combined with high-sensitive C-reactive protein and blood lipid index detection in coronary heart disease

作　　者：邓世忠 

机构地区：[1]广东省茂名石化综合内科,525000

出　　处：《中国实用医药》2015年第18期64-65,共2页China Practical Medicine

摘　　要：目的探讨同型半胱氨酸(HCY)联合超敏C-反应蛋白(hs-CRP)和血脂类项目检测在冠心病中的临床价值。方法 90例冠心病患者设为观察组,90例健康体检者设为对照组。对两组的HCY、hsCRP和常见血脂类检测数据进行统计,并对各项数据进行对比分析。结果对照组的HCY、hs-CRP和常见血脂类测量值均优于观察组的测量值,两组比较差异具有统计学意义(P<0.05)。结论 HCY、hs-CRP和血脂类项目的检测在冠心病临床治疗中具有重要的意义和价值。Objective To investigate the clinical value of homocysteine（HCY） combined with highsensitive C-reactive protein（hs-CRP） and blood lipid index detection in coronary heart disease. Methods There were 90 coronary heart disease patients as observation group, and another 90 healthy people as control group. Detected data of HCY, hs-CRP, and normal blood lipid indexes were summarized in the two groups, and their data were comparatively analyzed. Results The control group had all higher detected values of HCY, hs-CRP, and normal blood lipid indexes than the observation group, and their difference had statistical significance（P〈0.05）. Conclusion Detection of HCY, hs-CRP, and normal blood lipid index contains important significance and value in clinical treatment of coronary heart disease.

关 键 词：同型半胱氨酸 超敏C-反应蛋白 血脂类项目 冠心病 

分 类 号：R541.4[医药卫生—心血管疾病]